has_role erlotinib 0 393.16886 393.443 CHEBI:40877 patent:US2010094004 AAKJLRGGTJKAMG-UHFFFAOYSA-N chebi_ontology pubmed:17889528 pubmed:30039303 CHEBI:114785 wikipedia.en:Erlotinib pubmed:30158288 pubmed:29687154 lincs.smallmolecule:LSM-1097 pubmed:17983745 A quinazoline compound having a (3-ethynylphenyl)amino group at the 4-position and two 2-methoxyethoxy groups at the 6- and 7-positions. [6,7-bis(2-methoxy-ethoxy)quinazoline-4-yl]-(3-ethynylphenyl)amine kegg.drug:D07907 erlotinibum hmdb:HMDB0014671 pubmed:15711537 pubmed:30071517 pubmed:29448920 drugcentral:1045 pubmed:16480284 pubmed:16014882 pubmed:16014883 pubmed:29579331 N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine reaxys:8798958 C22H23N3O4 erlotinib InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25) pdb-ccd:AQ4 cas:183321-74-6 N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine pubmed:12270171 drugbank:DB00530 C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1 [6,7-bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine pubmed:14684309 pubmed:30150014 organic heterocyclic compound antineoplastic agent protein kinase inhibitor